To Increase Patient Access
End Brain Cancer Mobile App to download your number one tool for navigating this disease.

November 24, 2023

I'm Going To Save Me, & Everyone After Me!

Restore Hope & Get That GIVING Feeling

Jenn Ortiz photo

“When [Jenn] was first diagnosed with Glioblastoma and learned she may have only 12-15 months to live, she allowed one tear to roll down her cheek, then said, ‘No, not me,’” shared Jennifer Keeler, Ivy Center Communications Specialist. Jenn was determined to beat the tumor and she did. When the brain tumor returned two years later, she resolved to keep fighting and was able to beat it again. Now, Jenn provides hope to other brain cancer patients as a Patient Advocate with the End Brain Cancer Initiative. 

Giving Tuesday was created in 2012 with a simple idea: a day that encourages people to do good. Over the past 10 years, this idea has grown into a year-round global movement that inspires hundreds of millions of people to give, collaborate, and celebrate generosity. Giving Tuesday's annual celebration of generosity will happen November 28!

“I’m going to save me, and everyone after me,” says Jenn Ortiz, an Arizona mom and two-time brain tumor survivor. "You can help us achieve this goal by donating to the End Brain Cancer Initiative for Giving Tuesday."

Jenn Ortiz at Ivy Brain Tumor Center

“It costs approximately $225 to help one patient gain access to life-saving treatments and resources. Help us reach our #GivingTuesday2023 Goal of $25,000 so we can continue our work of Advocacy, Outreach, & Education for the Brain Tumor Community. Learn more about the End Brain Cancer Initiative at

Help us continue the incredibly important work of connecting patients with centers of excellence and top doctors so they get the best care possible outside of the traditional "Standard of Care" - which simply isn't enough. 

RESTORE HOPE for patients like Jenn and their families who are affected by this devastating disease. Donate today by clicking below. 

Sponsor logos


Enhancing patient outcomes by expanding FDA-approved treatment modalities and fueling research in the pharma/bio/life sciences, device & diagnostic industries and by closing the existing GAP from initial diagnosis to IMMEDIATE AND EXPANDED ACCESS to specialists, researchers, advanced & innovative treatments, clinical trials and critical care with the ultimate goal of improving patient outcomes through updating and improving WHO & NCCN Guidelines and clinical practices related to Standard of Care for brain cancer patients.

TAX ID:26-2185614
corporate partners
upcoming events
About us
linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram